JA Ledermann

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

John Northover, Rob Glynne‐Jones, David Sebag‐Montefiore et al. · British Journal of Cancer · 2010 · 428 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

Rob Glynne‐Jones, Nicholas Counsell, Philip Quirke et al. · Annals of Oncology · 2014 · 297 citations · Full text

Medicine, Oncology, Surgery +16

Predicting biomarkers for ovarian cancer using gene-expression microarrays

T. Adib, Stephen Henderson, C. W. Perrett et al. · British Journal of Cancer · 2004 · 199 citations · Full text

Medicine, Gynecology, Oncology +17

Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial

JA Ledermann, Timothy Perren, FA Raja et al. · UCL Discovery (University College London) · 2013 · 102 citations

Medicine, Gynecology, Oncology +17